Trial Details
ENROLLING_BY_INVITATIONBasic Information
| Clinical ID | c875 |
|---|---|
| Identifier | NCT05905926 |
| Trial Title | Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: Tenapanor |
Participant Information
| Sponsor | Ardelyx |
|---|---|
| City | Foley |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-02-17 |
|---|---|
| Primary Completion Date | 2031-07 |
| Completion Date | 2031-10 |